79. Hyperpigmentation
Hyperpigmentation is a common, usually harmless condition in which patches of skin become darker in color than the normal surrounding skin. This darkening occurs when an excess of melanin, the brown pigment that produces normal skin color, forms deposits in the skin. Causes. Hyperpigmentation can be caused by sun damage, inflammation, or other skin injuries, including those related to acne vulgaris. People with darker skin tones are more prone to hyperpigmentation, especially with excess sun exposure. Many forms of hyperpigmentation are caused by an excess production of melanin. Hyperpigmentation can be caused by sun damage, inflammation, or other skin injuries, including those related to acne vulgaris. People with darker skin tones are more prone to hyperpigmentation, especially with excess sun exposure. Many forms of hyperpigmentation are caused by an excess production of melanin Hyperpigmentation can be diffuse or focal, affecting such areas as the face and the back of the hands. Melanin is produced by melanocytes at the lower layer of the epidermis. Melanin is a class of pigment responsible for producing colour in the body in places such as the eyes, skin, and hair. As the body ages, melanocyte distribution becomes less diffuse and its regulation less controlled by the body. UV light stimulates melanocyte activity, and where concentration of the
cells is greater, hyperpigmentation occurs.
High Impact List of Articles
-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Hair cortisol and chronic stress exposure in chronic Hepatitis B patients
Hie-Won Hann, Jerrold Meyer, Grace Park, Peter D Block, Hee-Soon Juon
Research Article: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 6
Acknowledgements: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Immunotherapy & cancer - making the past prologue Immunotherapeutic combinations for cancer
Susan F Slovin
Review: Clinical Trail Outcomes: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
American Society of Clinical Oncology 2012 annual meeting: new optimism for fighting platinum resistance
Maurie Markman
Interview: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
Relevant Topics in Clinical